Letters to the Editor

• Ventricular Support With Extracorporeal Membrane Oxygenation: A Double-edged Sword. Response

  Soraya Merchán, Javier Martín-Moreiras, Aitor Uribarri, Pedro L. Sánchez

  Rev Esp Cardiol. 2016;69:229-30

• Coronary Artery Dominance as a Prognostic Factor: In Anterior Myocardial Infarctions as Well? Response

  Emad Abu-Assi, Sergio Raposeiras-Roubin, José Ramón González-Juanatey

  Rev Esp Cardiol. 2016;69:86

• Coronary Artery Dominance as a Prognostic Factor: In Anterior Myocardial Infarctions as Well?

  Iván J. Núñez Gil, Gisela Feltes, Antonio Fernández-Ortiz

  Rev Esp Cardiol. 2016;69:86

• Infective Endocarditis: Cause or Consequence of Delayed Anterior Mitral Leaflet Perforation After Transcatheter Aortic Valve Implantation?

  Ignacio J. Amat-Santos, Carlos Cortés, Ana Revilla, José A. San Román

  Rev Esp Cardiol. 2016;69:87

• Antihypertensive Medication: On the Right Path? Response

  Virginia Greciano, Diego Macías Saint-Gerons, Diana González-Bermejo, Ferrán Catalá-López

  Rev Esp Cardiol. 2015;68:1191-2

• Antihypertensive Medication: On the Right Path?

  Carlos Escobar, Vivencio Barrios

  Rev Esp Cardiol. 2015;68:1191

• The “De Winter Pattern” Can Progress to ST-segment Elevation Acute Coronary Syndrome. Response

  José M. Montero-Cabezas, Frank van der Kley, Ioannis Karalis, Martin J. Schalij

  Rev Esp Cardiol. 2015;68:1043

• The “De Winter Pattern” Can Progress to ST-segment Elevation Acute Coronary Syndrome

  Miquel Fiol Sala, Antonio Bayés de Luna, Andrés Carrillo López, Javier García-Niebla

  Rev Esp Cardiol. 2015;68:1042-3

• Beta-blocker Use After an Acute Coronary Syndrome. Which one, in Whom, and for How Long?

  Alberto Cordero, Pilar Carrillo, Ramón López-Palop

  Rev Esp Cardiol. 2015;68:1040-1

• Does Education Level Predict Mortality After Myocardial Infarction Independently of Left Ventricular Function and Medical Treatment? Response

  Luciano Consuegra-Sánchez, Leticia Jaulent-Huertas, Marta Vicente-Gilabert, Antonio Melgarejo-Moreno

  Rev Esp Cardiol. 2015;68:1039-40

• Does Educational Level Predict Mortality After Myocardial Infarction Independently of Left Ventricular Function and Medical Treatment?

  Mehmet Eyuboglu

  Rev Esp Cardiol. 2015;68:1039

• Guidelines on the Management of Implantable Cardioverter-defibrillators at the End of Life

  Manuel Martínez-Sellés

  Rev Esp Cardiol. 2015;68:1044

• Guidelines on the Management of Implantable Cardioverter-defibrillators at the End of Life. Response

  Ignacio García-Bolao, Àngel Moya i Mitjans, Francisco Ruiz-Mateas

  Rev Esp Cardiol. 2015;68:1044-5

• Beta-blocker Use After an Acute Coronary Syndrome. Which one, in Whom, and for How Long? Response

  Sergio Raposeiras Roubín, Emad Abu-Assi, José Ramón González-Juanatey

  Rev Esp Cardiol. 2015;68:1041

• Are We Following the Recommendations of the Clinical Guidelines? Another Point of View

  Javier Gualis Cardona, Armando Pérez de Prado, Mario Castaño Ruiz, Felipe Fernández-Vázquez

  Rev Esp Cardiol. 2015;68:910

• Elevated Troponin Levels in Patients Without Acute Coronary Syndrome: What is the Real Diagnosis?

  Mehmet Eyuboglu

  Rev Esp Cardiol. 2015;68:912-3

• Elevated Troponin Levels in Patients Without Acute Coronary Syndrome: What is the Real Diagnosis? Response

  Alfredo Bardají, Germán Cediel, Anna Carrasquer

  Rev Esp Cardiol. 2015;68:913-4

• Factors Contributing to the Low Rate of Surgical Coronary Revascularization in Spain. Are We Following the Recommendations? Response

  Eduardo Vázquez Ruiz de Castroviejo, Juan A. Herrador Fuentes, Juan Carlos Fernández Guerrero

  Rev Esp Cardiol. 2015;68:912

• Factors Contributing to the Low Rate of Surgical Revascularization in Spain

  -->Iñigo Lozano, Jose M. Vegas, Juan Rondan, Eduardo Segovia

  Rev Esp Cardiol. 2015;68:911

• Comments on the Long-term Prognosis of Patients With Non–ST-segment Elevation Acute Myocardial Infarction and Coronary Arteries Without Significant Stenosis

  Teresa Lozano Palencia, Juan M. Ruiz-Nodar, Ángel Cequier-Fillat, César Morís de la Tassa, on behalf of the GYSCA registry investigators

  Rev Esp Cardiol. 2015;68:820-1